The role of the gut microbiota in nonalcoholic fatty liver disease (Q42838234)

8 November 2017

The role of the gut microbiota in nonalcoholic fatty liver disease (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

8 November 2017

0 references

1 reference

Ahmed Abu-Shanab

1

1 reference

PubMed ID

21045794

8 November 2017

Eamonn M M Quigley

series ordinal

2

1 reference

PubMed ID

21045794

8 November 2017

language of work or name

English

0 references

publication date

2 November 2010

1 reference

Nature Reviews Gastroenterology & Hepatology

8 November 2017

1 reference

8 November 2017

7

1 reference

8 November 2017

691-701

1 reference

8 November 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2010.172

8 November 2017

0 references

cites work

Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interactions revisited

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Neostigmine for the treatment of acute hepatic encephalopathy with acute intestinal pseudo-obstruction in a cirrhotic patient

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Intestinal permeability and liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Increased oro-cecal transit time in grade I or II hepatic encephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Patients with autonomic neuropathy are more likely to develop hepatic encephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Fisiopatología de la translocación y la peritonitis bacteriana espontánea en la cirrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Intestinal endotoxins as mediators of hepatic injury--an idea whose time has come again

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

The gut microbiota as an environmental factor that regulates fat storage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Diversity of the human intestinal microbial flora

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

An obesity-associated gut microbiome with increased capacity for energy harvest

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

31 March 2020

Obesity and gut flora

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Microbial ecology: human gut microbes associated with obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Human gut microbiota in obesity and after gastric bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Early differences in fecal microbiota composition in children may predict overweight.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Bacteroides thetaiotaomicron: a dynamic, niche‐adapted human symbiont

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Role of bile in intestinal barrier function and its inhibitory effect on bacterial translocation in obstructive jaundice in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Endocrine functions of bile acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Signalling links in the liver: knitting SOCS with fat and inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

TLR4 and Insulin Resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Metabolic endotoxemia initiates obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

TNF-alpha and insulin resistance: summary and future prospects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105-2108

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Innate immunity and intestinal microbiota in the development of Type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

A rat fatty liver transplant model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

The exogenous origin of trimethylamine in the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Hepatobiliary complications of total parenteral nutrition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Intestinal failure-associated liver disease: management and treatment strategies past, present, and future

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Increased orocecal transit time in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Jejunoileal bypass: change in the flora of the small intestine and its clinical impact.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Effect of antibiotics in the prevention of jejunoileal bypass-induced liver dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Recurrence of nonalcoholic steatohepatitis following liver transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Diabetes and the gastrointestinal tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Orocecal transit delay in obese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Ghrelin in the regulation of body weight and metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Actions and therapeutic pathways of ghrelin for gastrointestinal disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Serum adipokine and ghrelin levels in nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Small intestinal bacterial overgrowth, intestinal permeability, and non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Energy intake is associated with endotoxemia in apparently healthy men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

How we detect microbes and respond to them: the Toll-like receptors and their transducers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Cytokine regulation of liver injury and repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

The NF-kappa B and I kappa B proteins: new discoveries and insights

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Squalamine, a novel cationic steroid, specifically inhibits the brush-border Na+/H+ exchanger isoform NHE3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Antibiotics prevent liver injury in rats following long-term exposure to ethanol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

The role of the gut microbiota in energy metabolism and metabolic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Impact of inulin and oligofructose on gastrointestinal peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Effect of fat replacement by inulin or lupin-kernel fibre on sausage patty acceptability, post-meal perceptions of satiety and food intake in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Oligofructose promotes satiety in healthy human: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

High-fat diet determines the composition of the murine gut microbiome independently of obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Lactic acid bacteria prevent alcohol-induced steatohepatitis in rats by acting on the pathways of alcohol metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Experimental acute alcohol pancreatitis-related liver damage and endotoxemia: synbiotics but not metronidazole have a protective effect

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Gut-liver axis: a new point of attack to treat chronic liver damage?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Composition of cecal bile acids in ex-germfree mice inoculated with human intestinal bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

A special fondness for lactobacilli

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Preventive effect of lactobacillus delbrueckii subsp. bulgaricus on the oxidation of LDL

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Effects of consumption of probiotics and prebiotics on serum lipid levels in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Dietary combination of soy with a probiotic or prebiotic food significantly reduces total and LDL cholesterol in mildly hypercholesterolaemic subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Probiotics in inflammatory bowel disease: is it all gut flora modulation?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.172

Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.

31 March 2020

1 reference

12 December 2020

Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth

1 reference

12 December 2020

Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions

1 reference

12 December 2020

Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss

1 reference

12 December 2020

Leptin deficiency enhances sensitivity to endotoxin-induced lethality.

1 reference

12 December 2020

The natural history of nonalcoholic fatty liver disease: a clinical histopathological study

1 reference

12 December 2020

Assessing the permeability of the gastrointestinal mucosa after oral administration of phenolsulfonphthalein

1 reference

12 December 2020

TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells

1 reference

12 December 2020

Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model

1 reference

12 December 2020

[Patients with liver cirrhosis: mouth-cecum transit time and gastric emptying of solid foods]

1 reference

12 December 2020

Bacterial overgrowth in small intestine in patients with liver cirrhosis

1 reference

12 December 2020

Cisapride decreasing orocecal transit time in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Increased growth of Bifidobacterium and Eubacterium by germinated barley foodstuff, accompanied by enhanced butyrate production in healthy volunteers.

1 reference

12 December 2020

Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics.

1 reference

12 December 2020

Hepatic steatosis after intestinal bypass--prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition

1 reference

12 December 2020

Choline deficiency: A cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation

1 reference

12 December 2020

Adaptation to overeating in lean and overweight men and women

1 reference

12 December 2020

The hydrophobic-hydrophilic balance of bile salts. Inverse correlation between reverse-phase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities.

1 reference

12 December 2020

Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies

1 reference

12 December 2020

[Intestinal bacteria overgrowth in chronic hepatopathies]

1 reference

12 December 2020

Prevalence of gastrointestinal symptoms in obese and normal weight binge eaters.

1 reference

12 December 2020

Regulation of bile acid synthesis. III. Correlation between biliary bile salt hydrophobicity index and the activities of enzymes regulating cholesterol and bile acid synthesis in the rat

1 reference

12 December 2020

Formation of methylamines from ingested choline and lecithin.

1 reference

12 December 2020

10.1038/NRGASTRO.2010.172

Identifiers

DOI

1 reference

8 November 2017

1 reference

PubMed ID

21045794